About Index Trending news
Analyze
Pricing
VentiRx Pharmaceuticals

VentiRx Pharmaceuticals

Work at VentiRx Pharmaceuticals? Add yourself to this profile

VentiRx Pharmaceuticals

VentiRx Pharmaceuticals develops novel TLR8 therapeutics for the treatment of cancer, allergy, and respiratory and autoimmune diseases.

Elsewhere

Alexa global traffic share

23 Sep 2014
$50,600,000
Venture capital (Series B)
Added by

SEC FORM D/A

sec